397 related articles for article (PubMed ID: 17258836)
1. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
[TBL] [Abstract][Full Text] [Related]
2. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats.
Sonaje K; Italia JL; Sharma G; Bhardwaj V; Tikoo K; Kumar MN
Pharm Res; 2007 May; 24(5):899-908. PubMed ID: 17377747
[TBL] [Abstract][Full Text] [Related]
3. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.
Italia JL; Bhatt DK; Bhardwaj V; Tikoo K; Kumar MN
J Control Release; 2007 Jun; 119(2):197-206. PubMed ID: 17399839
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of cyclosporine A-induced renal, hepatic and cardiac damages by ellagic acid in rats.
Yüce A; Ateşşahin A; Ceribaşi AO
Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):186-91. PubMed ID: 18816304
[TBL] [Abstract][Full Text] [Related]
5. A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer.
Kim S; Nishimoto SK; Bumgardner JD; Haggard WO; Gaber MW; Yang Y
Biomaterials; 2010 May; 31(14):4157-66. PubMed ID: 20185170
[TBL] [Abstract][Full Text] [Related]
6. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN
J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712
[TBL] [Abstract][Full Text] [Related]
7. Effect of ellagic acid, a natural polyphenol, on alcohol-induced prooxidant and antioxidant imbalance: a drug dose dependent study.
Devipriya N; Srinivasan M; Sudheer AR; Menon VP
Singapore Med J; 2007 Apr; 48(4):311-8. PubMed ID: 17384878
[TBL] [Abstract][Full Text] [Related]
8. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
Arulmozhi V; Pandian K; Mirunalini S
Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin.
Kashyap N; Viswanad B; Sharma G; Bhardwaj V; Ramarao P; Ravi Kumar MN
Biomaterials; 2007 Apr; 28(11):2051-60. PubMed ID: 17240443
[TBL] [Abstract][Full Text] [Related]
10. Injectable and biodegradable thermosensitive hydrogels loaded with PHBHHx nanoparticles for the sustained and controlled release of insulin.
Peng Q; Sun X; Gong T; Wu CY; Zhang T; Tan J; Zhang ZR
Acta Biomater; 2013 Feb; 9(2):5063-9. PubMed ID: 23036950
[TBL] [Abstract][Full Text] [Related]
11. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
He W; Horn SW; Hussain MD
Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249
[TBL] [Abstract][Full Text] [Related]
12. Improvement of cisplatin-induced injuries to sperm quality, the oxidant-antioxidant system, and the histologic structure of the rat testis by ellagic acid.
Türk G; Ateşşahin A; Sönmez M; Ceribaşi AO; Yüce A
Fertil Steril; 2008 May; 89(5 Suppl):1474-81. PubMed ID: 17681317
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering.
Yilgor P; Tuzlakoglu K; Reis RL; Hasirci N; Hasirci V
Biomaterials; 2009 Jul; 30(21):3551-9. PubMed ID: 19361857
[TBL] [Abstract][Full Text] [Related]
14. Dose-response effect of ellagic acid on circulatory antioxidants and lipids during alcohol-induced toxicity in experimental rats.
Devipriya N; Sudheer AR; Menon VP
Fundam Clin Pharmacol; 2007 Dec; 21(6):621-30. PubMed ID: 18034663
[TBL] [Abstract][Full Text] [Related]
15. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
Chung TW; Wang SS; Tsai WJ
Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
[TBL] [Abstract][Full Text] [Related]
17. Enhanced oral bioavailability and antioxidant profile of ellagic acid by phospholipids.
Murugan V; Mukherjee K; Maiti K; Mukherjee PK
J Agric Food Chem; 2009 Jun; 57(11):4559-65. PubMed ID: 19449806
[TBL] [Abstract][Full Text] [Related]
18. Effects of ellagic acid by oral administration on distribution and metabolism of 2-aminofluorene in Sprague-Dawley rats.
Ho CC; Lai YS; Wang DY; Chen YS; Lee JH; Tang NI; Chung JG
In Vivo; 2005; 19(1):143-56. PubMed ID: 15796167
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles incorporated in bilaminated films: a smart drug delivery system for oral formulations.
Cui F; He C; Yin L; Qian F; He M; Tang C; Yin C
Biomacromolecules; 2007 Sep; 8(9):2845-50. PubMed ID: 17665945
[TBL] [Abstract][Full Text] [Related]
20. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug.
Sahana DK; Mittal G; Bhardwaj V; Kumar MN
J Pharm Sci; 2008 Apr; 97(4):1530-42. PubMed ID: 17722098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
